It was suggested that CBX4 could enhance VEGF expression in HCC cells and promote angiogenesis through enhancing hypoxia-inducible factors (HIF-1α) SUMOylation and its transcriptional activity [57]. Here, HIF1A is linked to hepatocellular carcinoma.